EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-64
SponsorCortex Neurovascular
About this trial
EMBRACE-OBS is the first phase of the EMBRACE research program. This single-site observational registry accesses and analyzes patient-reported outcome data already collected through routine clinical care from adults with migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization. The study describes changes in headache frequency, headache severity, medication use, migraine-related disability, quality of life, and reported adverse events over time without influencing clinical care.
Eligibility criteria
Qualifiers
Adults aged 18 to 64 years
Diagnosis of migraine
Have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care, independent of study participation
Able and willing to provide informed consent
Disqualifiers
Age under 18 years
Pregnancy at the time of enrollment
Inability to provide informed consent
Inability to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments
Trial design
Treatments tested in this trial
- Middle Meningeal Artery Embolization
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov